COMPOUND B definition

COMPOUND B means the compound known as ABT-210, its enantiomers, racemates, isomers and any pharmaceutically acceptable salt or complex thereof, in its current and any other formulation, and including any Prodrugs and active metabolites, whether made before or after the Effective Date.
Sample 1Sample 2Sample 3
COMPOUND B means acyclovir, "Compound C" shall mean ketoprofen, and Compound D shall mean vitamins A/C/E.
Sample 1

Examples of COMPOUND B in a sentence

  • This document provides information on how to prepare proposals & apply for required services for the “PROVISION OF UNARMED SECURITY GUARD SERVICES FOR UNDP COMPOUND B, KABUL, AFGHANISTAN”.

  • COMPOUND B did not significantly modify APA, UA and RMP.In summary, no APD prolongation (APD60 or APD90) in canine Purkinje fibers was observed in the presence of COMPOUND A or COMPOUND B up to 10 µM despite IC50s on hERG in the low micromolar range for both drugs.

  • Nett reported there have been no further meetings with Winnebago County to discuss a countywide merger.

  • At the stimulation rate of 1 Hz, APD60 and APD90 were not significantly modified by COMPOUND B (0.1, 0.3, 1, 3 and 10 µM; n=6) at any of the concentrations tested.

  • WEINREICHS’ (1953) THREE TYPES OF BILINGUALS: COORDINATE (A), COMPOUND (B) AND SUBORDINATE (C).

  • Identification of the substance/mixture and of the company/undertaking Product identifier Product name CBnumber CASSynonyms: 2-(Dimethylaminomethyl)-1-cyclohexanone hydrochloride: CB7214624: 42036-65-7: 2-(Dimethylaminomethyl)-1-cyclohexanone hydrochloride,TRAMADOL RELATED COMPOUND B Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Uses advised against: For R&D use only.

  • PERUVIANA EXTRACTS 140 TABLE 4-16: 13C NMR OF COMPOUND A (APPENDIX 5) 143TABLE 4-17: 1H NMR OF THE GENIN PART OF COMPOUND A ((APPENDIX 6) 144TABLE 4-18: I H NMR OF SUGAR MOIETY OF COMPOUND A (APPENDIX 5) 145TABLE 4-19: 1HNMR ASSIGNMENT OF COMPOUND B (APPENDIX 14) 147LIST OF FIGURES FIGURE 1-1: GENERALISED POSSIBLE FATE OF TERMITICIDES AFTER APPLICATION TO SOIL (HTTP://WWW.FREE-CLIPART.NET) 4FIGURE 2-1: A SCHEMATIC CLASSIFICATION OF MAJOR TERMITE CONTROL MEASURES (ADAPTED FROM (VERMA ET AL.

  • Indeed, instead of a concentration-dependent APD prolonging effect developing at the plateau level and enhanced at lower stimulation rates, the effects of COMPOUND A and COMPOUND B on action potentials recorded from canine Purkinje fibers were characterized by an APD shortening starting at the plateau level, which subsequently reduced the duration of the final repolarization phase at both rates (Figure 2).The vehicle used was 0.1 % DMSO.

Related to COMPOUND B

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compound means [***].

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Exempt compound means the same as defined in Rule 2.

  • Program Technology means Program Know-How and Program Patents.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • SONIA Compounded IndexEnd means the SONIA Compounded Index Value on the date falling “p” London Business Days prior to (i) in respect of an Interest Accrual Period, the Interest Payment Date for such Interest Accrual Period, or (ii) if the Notes become due and payable prior to the end of an Interest Accrual Period, the date on which the Notes become so due and payable; and

  • Cell Line means the cell line, particulars of which are set out in Schedule 1.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).